Leaflet MILGAMMA N 40mg / 90mg / 0.25mg solution for injection


Indicated for: vitamin deficiency

Substance: benfotiamine + pyridoxine + cyanocobalamin (vitamins)

ATC: A11DBN1 (Alimentary tract and metabolism | Vitamin B1, plain and in combination with vitamin B6 and B12 | Vitamin B1 in combination with vitamin B6 and/or vitamin B12)

The combination of benfotiaminum, pyridoxinum, and cyanocobalaminum is used for the treatment of peripheral neuropathies and other conditions associated with vitamin B complex deficiencies. Benfotiamine is a fat-soluble form of vitamin B1, pyridoxine is vitamin B6, and cyanocobalamin is vitamin B12, all contributing to the normal functioning of the nervous system.

The medication is taken orally, usually once or twice daily, as directed by a doctor. The dosage is adjusted based on the severity of symptoms and the patient's response.

Common side effects include nausea, abdominal discomfort, and mild allergic reactions. In rare cases, more severe adverse effects such as severe allergic reactions may occur.

This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.

General data about MILGAMMA N 40mg / 90mg / 0.25mg

  • Substance: benfotiamine + pyridoxine + cyanocobalamin
  • Date of last drug list: 01-06-2016
  • Commercial code: W01611001
  • Concentration: 40mg / 90mg / 0.25mg
  • Pharmaceutical form: solution for injection
  • Quantity: 5
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for benfotiamine + pyridoxine + cyanocobalamin